ARID1A and cholangiocarcinoma: ARID1A protein loss correlated with lower OS significantly (P = 0.025). Median OS of the CCA patient cohort with intact expression pattern was 39.4 ± 5.626 months vs. 16.125 ± 4.725 months of ARID1A altered patients